Zhulun Wang
24Patents
7h-index
59Co-inventors
72Inventor score
Filing activity: Oct 9, 2002 → Dec 21, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7132438B2 | Benzimidazole derivatives | Chemistry; Metallurgy | 55 | Expired |
| US8324160B2 | Chimeric polypeptides and uses thereof | Chemistry; Metallurgy | 36 | Active |
| US9714276B2 | Growth differentiation factor 15 (GDF-15) polypeptides | Chemistry; Metallurgy | 15 | Active |
| US9862752B2 | Growth differentiation factor 15 (GDF-15) constructs | Chemistry; Metallurgy | 15 | Active |
| US10336798B2 | Growth differentiation factor 15 (GDF-15) polypeptides | Chemistry; Metallurgy | 9 | Active |
| US9382318B2 | ST2 antigen binding proteins | Emerging Cross-Sectional Technologies | 7 | Active |
| US10294303B2 | Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists | Chemistry; Metallurgy | 7 | Active |
| US10465009B2 | BCMA antigen binding proteins | Chemistry; Metallurgy | 6 | Active |
| US11541103B2 | Interleukin-21 mutein/ anti-PD-1 antibody conjugates | Chemistry; Metallurgy | 4 | Active |
| US11046774B2 | Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists | Chemistry; Metallurgy | 3 | Active |
| US10894814B2 | Growth differentiation factor 15 (GDF-15) constructs | Chemistry; Metallurgy | 3 | Active |
| US11518808B2 | Anti-PD-1 antibodies and methods of treatment | Chemistry; Metallurgy | 3 | Active |
| US9982054B2 | ST2 antigen binding proteins | Emerging Cross-Sectional Technologies | 2 | Active |
| US7635774B2 | Benzimidazole derivatives | Chemistry; Metallurgy | 2 | Active |
| US11739131B2 | Growth differentiation factor 15 (GDF-15) polypeptides | Chemistry; Metallurgy | 1 | Active |
| US10738110B2 | PAC1 antibodies and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11059895B2 | ST2 antigen binding proteins | Emerging Cross-Sectional Technologies | 1 | Active |
| US12252540B2 | Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR) | Chemistry; Metallurgy | 0 | Active |
| US11965029B2 | ST2 antigen binding proteins | Emerging Cross-Sectional Technologies | 0 | Active |
| US10227414B2 | ST2 antigen binding proteins | Emerging Cross-Sectional Technologies | 0 | Active |
| US11891435B2 | Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US8772296B2 | Benzamide derivatives and uses related thereto | Chemistry; Metallurgy | 0 | Active |
| US12060430B2 | Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR) | General | 0 | Revoked |
| US11248043B2 | Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.